In this issue:
Adalimumab achieves clinical remission in CD
CRC+IBD differs from CRC without IBD
Autoimmune liver disease: mortality, malignancy
Poor outcomes in primary sclerosing cholangitis
Stress worsens IBD
Antidepressants improve disease course in IBD
IBD impacts on QOL
Perioperative morbidity in obese IBD
Accelerated infliximab infusions are safe
Management of Crohn’s disease in smokers
Science Blog: Crohn’s disease and disease of the mouth
Please login below to download this issue (PDF)